And, besides, the lab testing is that good these days.  No "window period" concerns especially when HIV testing is performed using the p24 antigen

Nancy Rodway MD MPH FASCP FCAP FACOEM

Sent from Outlook


From: MCOH-EH <mcoh-eh-bounces@mylist.net> on behalf of Nancy Rodway <nrodway@hotmail.com>
Sent: Thursday, December 21, 2017 9:54 AM
To: Thrasher, Terri (Terri); MCOH/EH
Subject: Re: [MCOH-EH] BBP serial testing
 
We tailor the labs to the pathogen of concern, so we limit post exposure testing (except the t=0 series) of the exposed worker to those blood tests that detect any source positives. This is why:  If you have an initial Hep C neg in the source and then the employee was initially negative but then converts to positive, that would be very difficult to interpret.  Is this occupational?  Is this personal?  What do you do with the source patient?  You cannot notify the source patient of the private information of the exposed worker but you are assuming that the "source" of the Hep C was the source patient.  Do you tell the source?   How would the source be then "confirmed" serologically? Is this a public health concern?    etc etc.  
So, if the source is completely negative, the exposed worker has no further testing beyond t=0.  

Nancy Rodway MD MPH FACOEM



Sent from Outlook



From: MCOH-EH <mcoh-eh-bounces+nrodway=hotmail.com@mylist.net> on behalf of Thrasher, Terri (Terri) <Terri.Thrasher@cchmc.org>
Sent: Thursday, December 21, 2017 9:41 AM
To: MCOH/EH
Subject: Re: [MCOH-EH] BBP serial testing
 

We do the same

 

 

 

From: MCOH-EH [mailto:mcoh-eh-bounces@mylist.net] On Behalf Of Lawrence Budnick
Sent: Thursday, December 21, 2017 9:39 AM
To: MCOH/EH <mcoh-eh@mylist.net>
Subject: Re: [MCOH-EH] BBP serial testing

 

Both

 

Lawrence D. Budnick, MD, MPH

Director, Occupational Medicine Service

Professor of Medicine

Rutgers University - New Jersey Medical School

65 Bergen Street, Suite GA-167, Newark, NJ 07107

tel 973.972.2900

fax 973.972.2904

lawrence.budnick@rutgers.edu

 

CONFIDENTIALITY NOTICE: This email communication may contain private, confidential, or legally privileged information intended for the sole use of the designated and/or duly authorized recipient(s). If you are not the intended recipient or have received this email in error, please notify me immediately by email and permanently delete all copies of this email, including all attachments without reading them. If you are the intended recipient, please secure the contents in a manner that conforms to all applicable state and/or federal requirements related to privacy and confidentiality of such information. Thank you.

 

From: MCOH-EH [mailto:mcoh-eh-bounces@mylist.net] On Behalf Of Morelli, Karen J
Sent: Thursday, December 21, 2017 9:33 AM
To: 'mcoh-eh@mylist.net' <mcoh-eh@mylist.net>
Subject: [MCOH-EH] BBP serial testing

 

Our company has performed both HIV and Hep C serial testing on HCW’s that had an exposure to source patient that was positive for either one of the diseases (or if source unknown/untested).  I am curious if your facility tests for both or just the component that the source patient was positive for.  Example, Hep C positive source-do you test for both HIV and Hep C on HCW serial testing or just the Hep C?

Thank you,

 

Karen Morelli RN, BSN, Clinical Manager

WorkHealth LLC

973-7382

kmorelli@emhs.org

cid:image001.jpg@01D36DE2.F9E7A260